Home LiteratureArticle Details

PMID: 12377721 Published · ppublish English Comment Editorial Research Support, Non-U.S. Gov't Review

Re-endothelialization via bone marrow-derived progenitor cells: still another target of statins in vascular disease.

Arteriosclerosis, thrombosis, and vascular biology ·Vol. 22 ·No. 10 ·2002-10-01 ·Pages 1509-11

Thyberg J

Abstract

暂无摘要

MeSH Terms

Animals Anticholesteremic Agents/pharmacology Bone Marrow Cells/metabolism Carotid Artery Diseases/drug therapy,therapy Endothelium, Vascular/cytology,drug effects,metabolism,pathology Humans Muscle, Smooth, Vascular/drug effects,injuries,metabolism,pathology Stem Cells/drug effects,metabolism Tunica Intima/drug effects,metabolism,pathology

Chemicals

Anticholesteremic Agents

Authors & Affiliations

1 authors, click to expand affiliations / ORCID

Thyberg Johan

Article Info

Journal

Arteriosclerosis, thrombosis, and vascular biology

Abbr.

Arterioscler Thromb Vasc Biol

ISSN

1524-4636

DOI

10.1161/01.atv.0000036415.04486.01

Published

2002-10-01

Pages

1509-11

Language

English

Region

United States

NLM ID

9505803

Subset

Corrections

CommentOn

PMID: 12377731

External Links

PubMed source DOI: 10.1161/01.atv.0000036415.04486.01 View journal details

Analysis Services

Re-endothelialization via bone marrow-derived progenitor cells: still another target of statins in vascular disease.

Contact

WeChat Official Account